Location History:
- Aichi, JP (2014 - 2018)
- Nagoya, JP (2021 - 2022)
Company Filing History:
Years Active: 2014-2025
Title: Yoshimasa Arano: Innovator in Pharmaceutical Chemistry
Introduction
Yoshimasa Arano is a prominent inventor based in Aichi, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the field, particularly in the development of novel compounds for medical applications.
Latest Patents
Among his latest patents, Arano has focused on tetrahydroquinoline derivatives as P2X7 receptor antagonists. These inventions relate to tetrahydroquinoline derivatives or their pharmaceutically acceptable salts or prodrugs. The processes for their preparation, pharmaceutical compositions containing them, and their use in treating various disorders mediated via the P2X7 receptor are key aspects of his work.
Career Highlights
Throughout his career, Yoshimasa Arano has worked with notable companies such as Raqualia Pharma Inc. and Asahi Kasei Pharma Corporation. His expertise in pharmaceutical chemistry has allowed him to contribute to innovative solutions in drug development.
Collaborations
Arano has collaborated with esteemed colleagues, including Mikio Morita and Tatsuya Yamagishi, enhancing the impact of his research and inventions.
Conclusion
Yoshimasa Arano's work in developing tetrahydroquinoline derivatives showcases his dedication to advancing pharmaceutical science. His contributions continue to influence the treatment of various medical conditions, highlighting the importance of innovation in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.